Study of the Impact of DPD Activity on the Efficacy of Capecitabine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation
- Status
- RECRUITING
- Phase
- PHASE3
Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
- Status
- COMPLETED
- Phase
- PHASE2
EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)
- Status
- UNKNOWN
- Phase
- PHASE2
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3